RNS
Yellow Cake PLC

Yellow Cake PLC - Transaction in Own Shares

RNS Number : 4004Y
Yellow Cake PLC
09 September 2020
 

9 September 2020

 

 

 

Yellow Cake plc ("Yellow Cake" or the "Company") 

 

Transaction in Own Shares

 

Yellow Cake, a specialist company operating in the uranium sector with a view to holding physical uranium for the long term, announces that, on 8 September 2020, it purchased 20,000 ordinary shares of £0.01 each in the Company (the "Shares") on the London Stock Exchange through Canaccord Genuity Limited, in accordance with the terms of its enlarged share buyback programme announced on 8 July 2020 (the "Programme"). The Shares acquired will be held in treasury.

 

Date of purchase:

8 September 2020

Aggregate number of ordinary shares purchased:

20,000

Lowest price paid per share (pence per share):

211.00

Highest price paid per share (pence per share):

213.00

Volume weighted average price paid per share (pence per share):

212.38

 

Following the purchase, the Company will have 88,215,716 ordinary shares of £0.01 each in issue, of which 3,184,385 ordinary shares are held in treasury. Therefore, the total number of ordinary shares carrying voting rights will be 85,031,331.

 

The above figure of 85,031,331 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), the table below contains detailed information of the individual trades made by Numis Securities Limited as part of the Programme.



 

Individual transactions:

 

Number of shares
purchased

Transaction price
(pence per share)

Time of transaction

Execution venue

1,277

213.00

11:49:50

AIMX

1,223

213.00

11:49:50

AIMX

61

212.50

13:38:11

AIMX

667

212.50

13:38:11

AIMX

4,272

212.50

14:17:38

AIMX

246

212.50

14:17:57

AIMX

554

212.50

14:18:26

AIMX

2

212.50

14:19:21

AIMX

1,213

212.55

14:59:07

AIMX

1,000

212.50

15:20:16

AIMX

510

212.50

15:20:28

AIMX

188

212.50

15:36:54

AIMX

1,442

212.50

15:42:06

AIMX

1,463

212.50

15:42:06

AIMX

1,048

212.50

15:42:07

AIMX

1,547

212.50

15:42:07

AIMX

287

212.00

15:44:38

AIMX

2,000

211.50

16:23:50

AIMX

1,000

211.00

16:35:08

AIMX

 



 

ENQUIRIES: 

 

Yellow Cake plc

 

 

Andre Liebenberg, CEO

Carole Whittall, CFO

 

Tel: +44 (0) 153 488 5200

 

 

 

 

 

Nominated Adviser and Joint Broker: Canaccord Genuity Limited

 

Henry Fitzgerald-O'Connor

James Asensio

 

Georgina McCooke

Tel: +44 (0) 207 523 8000

 

 

 

 

 

Joint Broker: Berenberg

 

Matthew Armitt

Jennifer Wyllie

 

Detlir Elezi

 

 

Tel: +44 (0) 203 207 7800

 

 

 

 

 

Financial Adviser: Bacchus Capital Advisers

 

Peter Bacchus

Richard Allan

Tel: +44 (0) 203 848 1640

 

 

 

 

Investor Relations: Powerscourt

 

 

Peter Ogden

Linda Gu

 

Tel: +44 (0) 7793 858 211

 

 

 

 

 

 

 

 

 



 

ABOUT YELLOW CAKE

Yellow Cake is a London-listed company, headquartered in Jersey, which offers exposure to the uranium spot price. This is achieved through its strategy of buying and holding physical triuranium octoxide ("U3O8"). It may also seek to add value through the acquisition of uranium royalties and streams or other uranium related activities. Yellow Cake seeks to generate returns for shareholders through the appreciation of the value of its holding of U3O8 and its other uranium related activities in a rising uranium price environment. The business is differentiated from its peers by its ten-year Framework Agreement for the supply of U3O8 with Kazatomprom, the world's largest uranium producer. Yellow Cake currently holds 9.32 million lb of U3O8, all of which is held in storage in Canada and France. 

 

FORWARD LOOKING STATEMENTS

Certain statements contained herein are forward looking statements and are based on current expectations, estimates and projections about the potential returns of the Company and the industry and markets in which the Company will operate, the Directors' beliefs and assumptions made by the Directors. Words such as "expects", "anticipates", "should", "intends", "plans", "believes", "seeks", "estimates", "projects", "pipeline", "aims", "may", "targets", "would", "could" and variations of such words and similar expressions are intended to identify such forward looking statements and expectations. These statements are not guarantees of future performance or the ability to identify and consummate investments and involve certain risks, uncertainties and assumptions that are difficult to predict, qualify or quantify. Therefore, actual outcomes and results may differ materially from what is expressed in such forward looking statements or expectations. Among the factors that could cause actual results to differ materially are: uranium price volatility, difficulty in sourcing opportunities to buy or sell U3O8, foreign exchange rates, changes in political and economic conditions, competition from other energy sources, nuclear accident, loss of key personnel or termination of the services agreement with 308 Services Limited, changes in the legal or regulatory environment, insolvency of counterparties to the Company's material contracts or breach of such material contracts by such counterparties. These forward-looking statements speak only as at the date of this announcement. The Company expressly disclaims any obligation or undertaking to disseminate any updates or revisions to any forward looking statements contained herein to reflect any change in the Company's expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based unless required to do so by applicable law or the AIM Rules.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSLPMMTMTAMTLM
NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of...

FOR OUR FULL DISCLAIMER CLICK HERE
Proactive financial news: fast, accessible, and actionable articles and videos for the global investment audience.